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The long QT syndrome (LOTS) is a cardiac disease characterised by prolonged ventricular
repolari;ation ánd high risk of malignant arrhythmias. LQTS is divided into two groups: inherited
and acquired forms. Ã great number of exogenous factors can cause acquired LQTS, usually by
acting on the same ion channels implicated in the inherited LQTS. These factors include
non-ðardiac and heart-targeted drugs. Abnormal prolonged repolarisation of the card¡ac action
potential can be revealedãn the elãctrocardiogram as an abnormal prolongation of the QT interval
and it is one of the mechanisms that predisposes to arrhythmias.
One of the channels involved in the control of the repolarisation phase is the human ether-a-go-go
(HERG) channel. HERG gene encodes a voltage gated potassium channel that mediates the rapid
òompoáent of the cardiaJOetayeA rect¡f¡er designated as lKr. Due to the voltage-dependent
prop'"rties of the HERG channê1, lKr displays peak activity during the repolarisation phase of the
äctibn potential. Drugs belonging to different chemical classes and with different therapeutic
indications are able to produðe ãardiotoxic effects by means of HERG channel inhibition. One of
the non-cardiac drugs äcting on HERG channels and producing ventricular arrhythmias is the
widely used prokineic agen-l cisapride. For a better understanding of the mechanisms underlying
cardiótoxic effects of cisãpride, our study proposes new voltage protocols that simulate the cardiac
action potential in in vitro'conditions. ln this study we used COST cells transiently transfected with
HERG cDNA, and the whole cell patch-clamp teòhnique to investigate the rate dependent block of
HERG channels by cisapride. Simplified simulated cardiac action potential(SCAP).waveforms at
varying rates (4S, ô0, tiO and 180 SCAPs/min) have been used for in vitro simulations of normal
and high rate heartbeats. All experiments were carried out at 37'C.
ln the þresence of a therapeutic concentration of cisapride (200nM) there is no appare.nt effect on
the iniiial phase of the HEiìG channel activation, however a clear rate dependg{ bloc.k of HERG
channel was observed. The percentage of HERG current blockade increased 2 fold when the rate
of SCAPs rose from 4S to 180 SCApJ/min. Our results suggest that cisapride should be taken with
caution by athletes and patients with tachycardia , LQTS or when simultaneous medication with
drugs that enhance the HERG channel block is used.
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